Paratek Pharmaceuticals, Inc. (PRTK) Social Stream
PARATEK PHARMACEUTICALS INC (PRTK) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRTK.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 3 | $27 | $10 | $17.333 | $2.19 | 691.46% |
| 2022-02-10 | 3 | $27 | $11 | $17.666 | $2.19 | 706.67% |
| 2022-03-14 | 3 | $27 | $11 | $17 | $2.19 | 676.26% |
| 2022-03-17 | 3 | $22 | $11 | $15.333 | $2.19 | 600.14% |
| 2022-05-04 | 3 | $30 | $11 | $19 | $2.19 | 767.58% |
| 2022-08-08 | 3 | $30 | $11 | $18.5 | $2.19 | 744.75% |
| 2022-11-04 | 3 | $30 | $11 | $18 | $2.19 | 721.92% |
| 2023-01-24 | 2 | $30 | $9 | $19.666 | $2.19 | 797.99% |
| 2023-03-16 | 2 | $30 | $7 | $19 | $2.19 | 767.58% |
| 2023-03-20 | 2 | $30 | $7 | $15.666 | $2.19 | 615.34% |
| 2023-04-17 | 3 | $24 | $7 | $13.666 | $2.19 | 524.02% |
| 2023-05-10 | 3 | $24 | $5 | $13 | $2.19 | 493.61% |
| 2023-05-11 | 3 | $24 | $5 | $11.666 | $2.19 | 432.69% |
| 2023-08-07 | 3 | $24 | $2.15 | $9.433 | $2.19 | 330.73% |
The Trend in the Analyst Price Target
Over the past 15 months, PRTK's average price target has gone down $9.07.
Over the past 39 weeks, PRTK's average upside potential has been 669.38%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-24 | 1 | 30 | 9 | 19.666 | 2.09 | 840.96% |
| 2023-03-20 | 2 | 10 | 7 | 8.500 | 1.37 | 520.44% |
| 2023-03-20 | 2 | 30 | 7 | 15.666 | 1.37 | 1043.5% |
| 2023-05-10 | 3 | 24 | 5 | 13.000 | 1.87 | 595.19% |
| 2023-05-11 | 3 | 24 | 5 | 11.666 | 1.82 | 540.99% |
PRTK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 1 | 0 | 2 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
PRTK's average broker recommendation rating worsened by 1.33 over the prior 122 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRTK as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, PARATEK PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 2073.07% of them.
- In the context of all US stocks, PARATEK PHARMACEUTICALS INC's number of analysts covering the stock is higher than 134.6% of them.
- PARATEK PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1765.45% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, PARATEK PHARMACEUTICALS INC's average analyst price target is greater than 630.8% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PARATEK PHARMACEUTICALS INC are VBIV, ATNF, and GTHX.
View All Top Stocks by Price Target
Is PRTK a Buy, Hold or Sell? See the POWR Ratings now!